WOCKHARDT GROUP ASSETS UP FOR GRABS

The Wockhardt Group, previously a prominent player in the pharmaceutical industry, is facing monumental distress. With mounting debts and a struggling business, the group's valuable assets are now headed to market. This sudden shift in fortunes has sent shockwaves through the industry, raising eyebrows among analysts. It remains unknown who will u